Careology raises £1.1m in seed funding from angel investors to expand its cancer care platform.
The financing will support team growth and technology development following the platform rollout earlier this year.
Careology provides a digital platform for cancer care that connects patients with their families and healthcare providers. The data-driven system aims to help individuals manage their diagnosis more effectively.
London-based health-tech platform Careology has secured £1.1m in seed funding from a group of prominent UK health and technology angel investors. The capital will be directed towards team expansion, sales and marketing initiatives, and technological development.
Founded to help cancer patients feel more in control of their treatment, the company connects individuals directly to their medical teams and families for real-time monitoring. Following its initial rollout earlier in the year, the business has also bolstered its board of directors with the appointments of Dr Henry Carleton and Alan Marks.
From the founder
"I am delighted to announce this funding round which will help us accelerate our launch plans, firmly establishing Careology in the market. Careology helps those affected by cancer feel supported and achieve the best possible outcome, with wide ranging benefits for healthcare providers and medical insurance companies."
Paul Landau
CEO and Founder at Careology
Use of funds
- 01Grow the team
- 02Invest in sales and marketing
- 03Continue product development